Marc Hild

机构：Novartis (Switzerland), Novartis (China) · ORCID：0000-0001-6039-2518

发表论文 50 篇 · 总被引 10463 次 · h-index 28

代表论文

SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice (2015 · Nature Chemical Biology · 被引 432)
Notch2 Is Required for Inflammatory Cytokine-Driven Goblet Cell Metaplasia in the Lung (2014 · Cell Reports · 被引 257)
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery (2018 · Nature Communications · 被引 243)
Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA) (2018 · Journal of Medicinal Chemistry · 被引 134)
An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion (2022 · Nature Communications · 被引 123)
Production of 3‐D Airway Organoids From Primary Human Airway Basal Cells and Their Use in High‐Throughput Screening (2016 · Current Protocols in Stem Cell Biology · 被引 96)